Non-syndromic urogenital tract malformation of male

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:182121
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-syndromic urogenital tract malformation of male refers to a group of congenital structural abnormalities affecting the male urogenital system that occur in isolation, meaning they are not part of a broader recognizable genetic syndrome. These malformations can involve the kidneys, ureters, bladder, urethra, penis, testes, or other reproductive structures. Common examples include hypospadias (abnormal positioning of the urethral opening), cryptorchidism (undescended testes), renal agenesis or dysplasia, vesicoureteral reflux, and posterior urethral valves. These conditions are typically identified at birth or during early childhood, often through physical examination or prenatal ultrasound screening. The clinical significance of these malformations varies widely depending on the specific structure affected and the severity of the anomaly. Some cases may be mild and require only monitoring, while others can lead to significant complications including urinary obstruction, recurrent urinary tract infections, impaired renal function, and potential effects on fertility. The etiology is considered multifactorial in most cases, involving a combination of genetic susceptibility and environmental factors, though specific genetic variants have been implicated in certain subtypes. Treatment is primarily surgical and depends on the type and severity of the malformation. Hypospadias repair, orchiopexy for undescended testes, and reconstructive procedures for urethral or ureteral anomalies are among the most commonly performed interventions. Long-term follow-up by urologists and nephrologists may be necessary to monitor kidney function, urinary tract health, and reproductive outcomes. Early diagnosis and appropriate management generally lead to favorable outcomes for most patients.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-syndromic urogenital tract malformation of male.

View clinical trials →

No actively recruiting trials found for Non-syndromic urogenital tract malformation of male at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-syndromic urogenital tract malformation of male community →

No specialists are currently listed for Non-syndromic urogenital tract malformation of male.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-syndromic urogenital tract malformation of male.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-syndromic urogenital tract malformation of maleForum →

No community posts yet. Be the first to share your experience with Non-syndromic urogenital tract malformation of male.

Start the conversation →

Latest news about Non-syndromic urogenital tract malformation of male

No recent news articles for Non-syndromic urogenital tract malformation of male.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Non-syndromic urogenital tract malformation of male

What is Non-syndromic urogenital tract malformation of male?

Non-syndromic urogenital tract malformation of male refers to a group of congenital structural abnormalities affecting the male urogenital system that occur in isolation, meaning they are not part of a broader recognizable genetic syndrome. These malformations can involve the kidneys, ureters, bladder, urethra, penis, testes, or other reproductive structures. Common examples include hypospadias (abnormal positioning of the urethral opening), cryptorchidism (undescended testes), renal agenesis or dysplasia, vesicoureteral reflux, and posterior urethral valves. These conditions are typically ide

How is Non-syndromic urogenital tract malformation of male inherited?

Non-syndromic urogenital tract malformation of male follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Non-syndromic urogenital tract malformation of male typically begin?

Typical onset of Non-syndromic urogenital tract malformation of male is neonatal. Age of onset can vary across affected individuals.